RG
CNTX icon

Retirement Group’s Context Therapeutics CNTX Stock Holding History

Retirement Group’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$214 Hold
155
– – ﹤0.01% 795
2023
Q4 		$175 Hold
155
– – ﹤0.01% 794
2023
Q3 		$234 Hold
155
– – ﹤0.01% 723
2023
Q2 		$248 Hold
155
– – ﹤0.01% 757
2023
Q1 		$0 Hold
155
– – ﹤0.01% 693
2022
Q4 		$0 Hold
155
– – ﹤0.01% 647
2022
Q3 		$0 Hold
155
– – ﹤0.01% 542
2022
Q2 		$0 Hold
155
– – ﹤0.01% 750
2022
Q1 		$0 Hold
155
– – ﹤0.01% 750
2021
Q4 		$0 Buy
+155
New +$773 ﹤0.01% 713

Other funds holding CNTX

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Retirement Group's CNTX Position: Q1 2024 in Review

Retirement Group held its Context Therapeutics (CNTX) position steady in Q1 2024 at 155 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Retirement Group first reported a position in CNTX in Q4 2021 and has held it in 10 quarters since. The position peaked at $248 in Q2 2023. 25 funds tracked by Wall St. Rank hold CNTX as of Q1 2024.

  • Retirement Group held 155 shares of Context Therapeutics worth $214 as of Q1 2024.
  • Retirement Group left its Context Therapeutics share count unchanged in Q1 2024.
  • Context Therapeutics made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #795 holding.
  • Retirement Group first reported a position in Context Therapeutics in Q4 2021 and has held it in 10 quarters since.
  • Retirement Group's Context Therapeutics position peaked at $248 in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Context Therapeutics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.